NCT00158210View on ClinicalTrials.gov

Rivastigmine For Methamphetamine Dependent Individuals

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Substance-Related Disorders
Interventions
DRUG

Rivastigmine

Trial Locations (1)

90024

University of California - Los Angeles, Los Angeles

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00158210 - Rivastigmine For Methamphetamine Dependent Individuals | Biotech Hunter | Biotech Hunter